GNOMvsGNMXETF Comparison
VS
Global X Genomics & Biotechnology ETF (GNOM) and Corgi Genomics & Precision Medicine ETF (GNMX) belong to the same industry segment: BioTech & Genomics. In contrast, GNMX's top sector exposures are Healthcare. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of GNOM and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GNOM vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM GNMX | +4.57%+5.34% | +27.28%+28.56% | +36.95%n/a | +69.95%n/a | +43.87%n/a | -32.85%n/a |
| Flows | GNOM GNMX | +$2M+$1M | +$18M+$761K | +$21M- | +$15M- | -$54M- | -$42M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM GNMX | +37.85%+33.12% | +30.56%n/a | +30.36%n/a | +33.83%n/a |
| Max drawdown | GNOM GNMX | -8.57%-8.53% | -18.16%n/a | -43.10%n/a | -71.04%n/a |
| Max drawdown duration | GNOM GNMX | 32d32d | 145dn/a | 674dn/a | 1818dn/a |
Trading data
GNOM | GNMX | |
Last sale 9/14/2026 at 1:30 PM | $63.57 | |
| Previous close 09/11/2026 | $62.22 | |
| Consolidated volume 09/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexGNOM | GNMX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/14/2026 at 1:30 PM
Live
Closed
GNOM | GNMX | |
|---|---|---|
| Last price | $63.57 | – |
| 1D performance | +2.17% | – |
| AuM | $93.74 M | $2.56 M |
| E/R | 0.5% | 0.35% |
Characteristics
GNOM | GNMX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Global X | Corgi Funds |
| Benchmark | Solactive Genomics Index | - |
| N° of holdings | - | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
GNOM
Data will be available soon
GNMX
USA
87.58%
Other
12.42%
Sectors
GNOM
Data will be available soon
GNMX
Healthcare
96.78%
Other
3.22%
Advertisement
Diversification
GNOM
Data will be available soon
GNMX
Total weight of top 15 holdings out of 15
55.56%
Top 15 holdings
Data as of January 1, 1970
GNOM
Data will be available soon
GNMX
Thermo Fisher Scientific, Inc.
9.28%
Vertex Pharmaceuticals, Inc.
6.75%
Illumina, Inc.
4.56%
Guardant Health, Inc.
4.26%
Revolution Medicines, Inc.
3.92%
Incyte Corp.
3.38%
Moderna, Inc.
3.06%
Genmab A/S
2.96%
Alnylam Pharmaceuticals, Inc.
2.77%
Bio-Techne Corp.
2.67%
10X Genomics, Inc.
2.58%
BioMarin Pharmaceutical, Inc.
2.55%
Arrowhead Pharmaceuticals, Inc.
2.34%
Krystal Biotech, Inc.
2.30%
QIAGEN NV
2.18%
Frequently asked questions about GNOM and GNMX
Which ETF is bigger: GNOM or GNMX?
As of September 11, 2026, GNOM holds $93.74 M in assets under management (AUM), while GNMX manages $2.56 M.
Advertisement
Advertisement
